| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J0741 |
Injection, cabotegravir and rilpivirine, 2mg/3mg |
126 |
117 |
$521K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
8,398 |
1,753 |
$196K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,374 |
2,197 |
$123K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,455 |
1,764 |
$123K |
| M0245 |
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring |
67 |
67 |
$26K |
| 96367 |
|
2,366 |
757 |
$23K |
| 99222 |
Initial hospital care, per day, moderate complexity |
306 |
300 |
$22K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
33 |
33 |
$14K |
| M0247 |
Intravenous infusion, sotrovimab, includes infusion and post administration monitoring |
20 |
20 |
$8K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
130 |
130 |
$5K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
478 |
312 |
$4K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
253 |
234 |
$3K |
| 99215 |
Prolong outpt/office vis |
28 |
26 |
$1K |
| 99233 |
Prolong inpt eval add15 m |
15 |
12 |
$885.46 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
71 |
68 |
$499.80 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
58 |
48 |
$10.53 |